Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

J Transl Med. 2021 May 10;19(1):197. doi: 10.1186/s12967-021-02869-4.

¹ Stem Cell Institute, Panama City, Panama. nhriordan@gmail.com.
² MediStem Panama Inc., Clayton, City of Knowledge, Panama City, Panama. nhriordan@gmail.com.
³ MediStem Panama Inc., Clayton, City of Knowledge, Panama City, Panama.
⁴ Stem Cell Institute, Panama City, Panama.
⁵ Cook Advanced Technologies, West Lafayette, IN, USA.
⁶ Cook Medical Technologies, Bloomington, IN, USA.
⁷ Department of Surgery, University of Miami School of Medicine, Miami, FL, USA.
⁸ Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute and Pacifc Neuroscience Institute, Santa Monica, CA, USA.

No abstract available

Publication types